BIOGEN APPOINTS MULLEN TO VICE PRESIDENT-OPERATIONS
BIOGEN APPOINTS MULLEN TO VICE PRESIDENT-OPERATIONS CAMBRIDGE, Mass., Dec. 16 /PRNewswire/ -- Biogen, Inc.
(NASDAQ: BGEN) today announced the appointment of James C. Mullen to the position of vice president-Operations. Mullen, who previously was senior director of Operations, will continue to be responsible for all process development, manufacturing and facilities management of the company.
Mullen joined Biogen in 1989 as director of Facilities and Engineering. He was promoted to his present duties in 1990. Prior to arriving at Biogen, Mullen was employed by SmithKline & French International in various management positions. Mullen holds a B.S. from Rensselaer Polytechnic Institute and an M.B.A. from Villanova University. Biogen, Inc., headquartered in Cambridge, Mass., is a biopharmaceutical company principally engaged in developing and manufacturing drugs from human healthcare through genetic engineering. The company's revenues are generated from the worldwide sales by licensees of five products, including alpha interferon, hepatitis vaccines and hepatitis diagnostic products. Biogen is focused primarily on developing and testing products for the treatment of cardiovascular disease, inflammatory diseases, AIDS and certain cancers. -0- 12/16/91 /CONTACT: Kenneth M. Bate of Biogen, 617-252-9200/ (BGEN) CO: Biogen, Inc. ST: Massachusetts IN: MTC SU: PER
SH -- NE006 -- 2463 12/16/91 11:21 EST
|Printer friendly Cite/link Email Feedback|
|Date:||Dec 16, 1991|
|Previous Article:||MCI OFFERS UP TO 35 PERCENT SAVINGS ON CHRISTMAS AND NEW YEAR'S DAY CALLS|
|Next Article:||BIOGEN, INC. APPOINTS AMY D. SELTZER AS DIRECTOR -- INVESTOR RELATIONS|